We are live on
!
Find out more
ArriVent BioPharma
AVBP
AVBP
106 hedge funds and large institutions have $712M invested in ArriVent BioPharma in 2025 Q3 according to their latest regulatory filings, with 18 funds opening new positions, 46 increasing their positions, 19 reducing their positions, and 11 closing their positions.
New
Increased
Maintained
Reduced
Closed
more repeat investments, than reductions
Existing positions increased: | Existing positions reduced:
more first-time investments, than exits
New positions opened: | Existing positions closed:
more funds holding
Funds holding: →
less capital invested
Capital invested by funds: $ → $
3.21% less ownership
Funds ownership: 98.29% → 95.07% (-3.2%)
17% less funds holding in top 10
Funds holding in top 10: 6 → 5 (-1)
76% less call options, than puts
Call options by funds: $424K | Put options by funds: $1.75M
Holders
106
Holding in Top 10
5
Calls
$424K
Puts
$1.75M
Top Buyers
| 1 | +$26.5M | |
| 2 | +$10.7M | |
| 3 | +$8.84M | |
| 4 |
UBS Group
Zurich,
Switzerland
|
+$8.08M |
| 5 |
Morgan Stanley
New York
|
+$5.71M |
Top Sellers
| 1 | -$5.75M | |
| 2 | -$1.49M | |
| 3 | -$1.17M | |
| 4 |
Verition Fund Management
Greenwich,
Connecticut
|
-$814K |
| 5 |
Citadel Advisors
Miami,
Florida
|
-$733K |